<?xml version="1.0" encoding="UTF-8"?>
<QuestionnaireResponse xmlns="http://hl7.org/fhir">
  <id value="RegulatoryQA-ID001-Response"/>
  <meta>
    <versionId value="1"/>
    <lastUpdated value="2025-11-15T14:59:00-05:00"/>
    <profile value="http://hl7.org/fhir/uv/brr/StructureDefinition/RegulatoryQuestionnaireResponse"/>
  </meta>

  <!-- Narrative -->
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
      <h2>Response to Regulatory Questionnaire ID001</h2>
      <p><b>Procedure:</b> EMEA/H/C/005432/II/0023</p>
      <p><b>Product:</b> ExampleDrug 10 mg Tablets</p>
      <p><b>Submitted by:</b> SynthPharma AG</p>
      <p><b>Submitted to:</b> European Medicines Agency (EMA)</p>
      <p><b>Date:</b> November 15, 2025</p>
      <hr/>
      <p>This response addresses all administrative, labeling, and CMC stability questions for the Type II Variation.</p>
    </div>
  </text>

  <!-- Identifiers -->
  <identifier>
    <system value="http://hl7.org/fhir/uv/brr/identifier/qa-request"/>
    <value value="ID001"/>
  </identifier>
  <identifier>
    <system value="https://ema.europa.eu/procedure-number"/>
    <value value="EMEA/H/C/005432/II/0023"/>
  </identifier>

  <!-- Reference to original Questionnaire -->
  <questionnaire value="http://hl7.org/fhir/uv/brr/Questionnaire/brr-regulatory-qa-questionnaire"/>

  <status value="completed"/>
  <subject>
    <reference value="MedicinalProductDefinition/example-drug-10mg"/>
    <display value="ExampleDrug 10 mg Tablets"/>
  </subject>
  <authored value="2025-11-15T14:59:00-05:00"/>

  <!-- SENDER: SynthPharma AG (MAH) — sending the response -->
  <contact>
    <purpose>
      <coding>
        <system value="http://hl7.org/fhir/uv/brr/CodeSystem/contact-purpose"/>
        <code value="SENDER"/>
        <display value="Sender (Marketing Authorization Holder)"/>
      </coding>
    </purpose>
    <organization>
      <reference value="Organization/synthpharma"/>
      <identifier>
        <system value="urn:oid:1.3.6.1.4.1.519.1"/>
        <value value="DUNS-123456789"/>
      </identifier>
      <display value="SynthPharma AG"/>
      <address>
        <line value="123 Synthetic Research Blvd"/>
        <city value="Basel"/>
        <postalCode value="4000"/>
        <country value="CH"/>
      </address>
    </organization>
    <telecom>
      <system value="email"/>
      <value value="john.doe@synthpharma.example"/>
    </telecom>
    <telecom>
      <system value="phone"/>
      <value value="+41-61-123-4567"/>
    </telecom>
    <extension url="http://hl7.org/fhir/uv/brr/StructureDefinition/contact-signature">
      <valueXhtml>
        <div xmlns="http://www.w3.org/1999/xhtml">
          <p style="margin:0; font-weight:bold;">Dr. John Doe</p>
          <p style="margin:0; font-style:italic;">Head of Regulatory Affairs</p>
          <p style="margin:0;">
            <b>SynthPharma AG</b><br/>
            Global Regulatory Strategy<br/>
            Basel, Switzerland
          </p>
          <p style="margin:0; color:#0066cc;">
            <a href="mailto:john.doe@synthpharma.example">john.doe@synthpharma.example</a>
          </p>
          <p style="margin:0; font-size:0.9em; color:#666;">
            123 Synthetic Research Blvd, 4000 Basel, Switzerland
          </p>
        </div>
      </valueXhtml>
    </extension>
  </contact>

  <!-- RECIPIENT: EMA — original sender of the question -->
  <contact>
    <purpose>
      <coding>
        <system value="http://hl7.org/fhir/uv/brr/CodeSystem/contact-purpose"/>
        <code value="RECIPIENT"/>
        <display value="Recipient (Health Authority)"/>
      </coding>
    </purpose>
    <organization>
      <reference value="Organization/ema"/>
      <identifier>
        <system value="https://ema.europa.eu/organization-id"/>
        <value value="EMA-ORG-001"/>
      </identifier>
      <display value="European Medicines Agency"/>
      <address>
        <line value="Domenico Scarlattilaan 6"/>
        <city value="Amsterdam"/>
        <postalCode value="1083 HS"/>
        <country value="NL"/>
      </address>
    </organization>
    <telecom>
      <system value="email"/>
      <value value="jane.doe@ema.europa.eu"/>
    </telecom>
    <telecom>
      <system value="phone"/>
      <value value="+31-88-781-6000"/>
    </telecom>
    <extension url="http://hl7.org/fhir/uv/brr/StructureDefinition/contact-signature">
      <valueXhtml>
        <div xmlns="http://www.w3.org/1999/xhtml">
          <p style="margin:0; font-weight:bold;">Dr. Jane Doe</p>
          <p style="margin:0; font-style:italic;">Scientific Officer</p>
          <p style="margin:0;">
            <b>Scientific and Regulatory Management</b><br/>
            Human Medicines Evaluation Division<br/>
            European Medicines Agency
          </p>
          <p style="margin:0; color:#0066cc;">
            <a href="mailto:jane.doe@ema.europa.eu">jane.doe@ema.europa.eu</a> | 
            <a href="tel:+31-88-781-6000">+31-88-781-6000</a>
          </p>
          <p style="margin:0; font-size:0.9em; color:#666;">
            Domenico Scarlattilaan 6, 1083 HS Amsterdam, Netherlands
          </p>
        </div>
      </valueXhtml>
    </extension>
  </contact>

  <!-- ====================== ANSWERS (exact match with Questionnaire) ====================== -->

  <!-- admin-1 -->
  <item>
    <linkId value="admin-1"/>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="1.0"/>
      <display value="1.0 Administrative Information"/>
    </code>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="1.1"/>
      <display value="1.1 Application Form"/>
    </code>
    <text value="Is the fee for the Type II variation fully paid and documented?"/>
    <answer>
      <valueString value="Yes, the fee was paid on June 25, 2025. Payment confirmation and receipt are included in the application form (see Section 1.1)."/>
    </answer>
  </item>

  <!-- admin-2 -->
  <item>
    <linkId value="admin-2"/>
    <code>
      <system value="http://hl7.org/fhir.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="1.0"/>
      <display value="1.0 Administrative Information"/>
    </code>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="1.1"/>
      <display value="1.1 Application Form"/>
    </code>
    <text value="Are all required metadata fields in the application form complete?"/>
    <answer>
      <valueString value="Yes, all required metadata fields are complete:
• MAH: SynthPharma AG
• Product: ExampleDrug 10 mg Tablets
• Procedure: EMEA/H/C/005432/II/0023
• Submission Date: 2025-06-25"/>
    </answer>
  </item>

  <!-- labeling-1 -->
  <item>
    <linkId value="labeling-1"/>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="1.3"/>
      <display value="1.3 Product Information"/>
    </code>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="1.3.1"/>
      <display value="1.3.1 SmPC, Labelling and Package Leaflet"/>
    </code>
    <text value="Do the updated storage conditions (2–8°C for 36 months) require additional patient guidance?"/>
    <answer>
      <valueString value="No additional patient guidance is required. The ePI clearly states: 'Store in a refrigerator (2°C – 8°C). Do not freeze.' The 36-month shelf life is supported by stability data and does not alter patient handling instructions."/>
    </answer>
  </item>

  <!-- labeling-2 -->
  <item>
    <linkId value="labeling-2"/>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="1.3"/>
      <display value="1.3 Product Information"/>
    </code>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="1.3.1"/>
      <display value="1.3.1 SmPC, Labelling and Package Leaflet"/>
    </code>
    <text value="Is the patient leaflet revised to clarify the extended shelf life?"/>
    <answer>
      <valueString value="Yes, the patient leaflet has been updated to state: 'Shelf life after first opening: 36 months when stored at 2–8°C'. The revised leaflet is included in the submission."/>
    </answer>
  </item>

  <!-- labeling-3 -->
  <item>
    <linkId value="labeling-3"/>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="1.3"/>
      <display value="1.3 Product Information"/>
    </code>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="1.3.1"/>
      <display value="1.3.1 SmPC, Labelling and Package Leaflet"/>
    </code>
    <text value="Is the updated ePI text sufficiently clear for all EU languages?"/>
    <answer>
      <valueString value="Yes, the ePI text has been translated into all EU languages and reviewed for clarity. All versions are linguistically validated. Status: English (Approved), French (Approved), German (Approved), others (Final review completed)."/>
    </answer>
  </item>

  <!-- cmc-1-DP-Stability -->
  <item>
    <linkId value="cmc-1-DP-Stability"/>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="3.2.P.8"/>
      <display value="3.2.P.8 Stability"/>
    </code>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="3.2.P.8.1"/>
      <display value="3.2.P.8.1 Stability Summary and Conclusion"/>
    </code>
    <text value="Are there any new stability studies conducted, or does the submission include only data from additional timepoints from previously submitted studies?"/>
    <answer>
      <valueString value="The submission includes both:
• Additional timepoints: Long-term data extended to 36 months for primary batches A-001, A-002, A-003.
• New stability studies: Two pilot-scale batches (B-001, B-002) in new Alu/Alu packaging, with 6-month accelerated (40°C/75% RH) and long-term (25°C/60% RH) data.
No protocol deviations occurred. All studies follow ICH Q1A(R2)."/>
    </answer>
  </item>

  <!-- cmc-2-DP-Stability -->
  <item>
    <linkId value="cmc-2-DP-Stability"/>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="3.2.P.8"/>
      <display value="3.2.P.8 Stability"/>
    </code>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="3.2.P.8.1"/>
      <display value="3.2.P.8.1 Stability Summary and Conclusion"/>
    </code>
    <text value="Does the data support all intended climatic zones?"/>
    <answer>
      <valueString value="Yes, the data supports all ICH climatic zones, including Zone IVb:
• Zone I/II: 25°C/60% RH (long-term), 40°C/75% RH (accelerated)
• Zone IVb: 30°C/75% RH (long-term) — data confirms compliance per WHO TRS 1010.
All batches remain within specification."/>
    </answer>
  </item>

  <!-- cmc-3-DP-Analytical Methods -->
  <item>
    <linkId value="cmc-3-DP-Analytical Methods"/>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="3.2.P.5"/>
      <display value="3.2.P.5 Control of Drug Product"/>
    </code>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="3.2.P.5.2"/>
      <display value="3.2.P.5.2 Analytical Procedures"/>
    </code>
    <text value="Are the test methods used the same as in the previously submitted stability information?"/>
    <answer>
      <valueString value="Yes, all test methods are identical to those validated in the original MAA. No changes were made. Methods remain stability-indicating for assay, impurities, and dissolution."/>
    </answer>
  </item>

  <!-- cmc-4-DP-Impurities -->
  <item>
    <linkId value="cmc-4-DP-Impurities"/>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="3.2.P.5"/>
      <display value="3.2.P.5 Control of Drug Product"/>
    </code>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="3.2.P.5.4"/>
      <display value="3.2.P.5.4 Impurities"/>
    </code>
    <text value="Are there any new degradation products identified within the newly submitted data?"/>
    <answer>
      <valueString value="No new degradation products were identified. All observed impurities correspond to previously qualified degradants. Levels remain below 0.10% (ICH Q3B(R2) threshold). No peaks above reporting threshold detected."/>
    </answer>
  </item>

  <!-- cmc-5-DP-Container Closure System -->
  <item>
    <linkId value="cmc-5-DP-Container Closure System"/>
    <code>
      <system value="http://hl7.org/fhir/uv/brr/CodeSystem/ctd-section"/>
      <code value="3.2.P.7"/>
      <display value="3.2.P.7 Container Closure System"/>
    </code>
    <text value="Any changes in the packaging configuration and/or storage of the samples during stability?"/>
    <answer>
      <extension url="http://hl7.org/fhir/uv/brr/StructureDefinition/questionnaire-itemRichText">
        <valueXhtml>
          <div xmlns="http://www.w3.org/1999/xhtml">
            <p>Yes, a change in packaging configuration was implemented:</p>
            <ul>
              <li><b>Original:</b> PVC/PVDC blister pack</li>
              <li><b>New:</b> Aluminum/aluminum (Alu/Alu) blister pack</li>
            </ul>
            <p>New stability studies (B-001, B-002) were initiated in the Alu/Alu system. Storage conditions remain unchanged: 25°C/60% RH (long-term), 40°C/75% RH (accelerated).</p>
            <img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAA..." 
                 alt="Alu/Alu blister cross-section" 
                 width="600" 
                 style="border:1px solid #ccc; margin:10px 0; display:block;" />
            <p style="font-size:0.9em; color:#555;">
              <b>Figure 1:</b> Cross-section of new Alu/Alu blister showing foil thickness and sealing layer.
            </p>
            <table border="1" style="width:100%; border-collapse:collapse; margin-top:8px;">
              <tr><th>Parameter</th><th>Original</th><th>New</th></tr>
              <tr><td>Material</td><td>PVC/PVDC</td><td>Alu/Alu</td></tr>
              <tr><td>Storage Condition</td><td>25°C/60% RH</td><td>Unchanged</td></tr>
            </table>
          </div>
        </valueXhtml>
      </extension>
      <valueString value="Yes, packaging changed from PVC/PVDC to Alu/Alu. New stability studies initiated. See rich text for diagram and details."/>
    </answer>
  </item>

</QuestionnaireResponse>